News | 05 August 2012
This week, the ratings of four Biotechnology stocks on Portfolio Grader are down. Each of these rates a ?D? (?sell?) or ?F? overall (?strong sell?). Keryx Biopharmaceuticals (NASDAQ:KERX) is on the decline this week, earning a D (?sell?) after ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)